stars 1 stars 2 stars 3

DiLab - inventing the future of Automated Blood Sampling. The DiLab AccuSampler is a fully automated system for blood sampling in tethered, freely-moving research animals. Since 2011 DiLab® is a part of VeruTech AB. DiLab was founded 1983 by Hans Axel Hansson (CEO, VeruTech AB). During the 90's the pharmaceutical company Novo Nordisk A/S in Denmark approched DiLab with a project. The aim was to build an instrument that automatically could handle the collection of blood instead of manual sampling. The result became the AccuSampler® and with this our first steps was taken in the ABS business (Automated Blood Sampling).

DiLab Questions

The DiLab annual revenue was $1 million in 2026.

4 people are employed at DiLab.

DiLab is based in New York, New York.

The NAICS codes for DiLab are [33, 339].

The SIC codes for DiLab are [384, 38].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users